Interventional Spine Announces FDA Clearance of Lordotic Opticage™

By Julie A. Vetalice

Interventional Spine, Inc. announced FDA clearance of the 80 Lumbar Lordotic Opticage™ Expandable Intervertebral Body Fusion Device, indicated for use with autogenous bone graft in patients with degenerative disc disease at one or two contiguous levels from L2-S1.

This device joins the Interventional Spine family of Opticage™ Expandable Interbody Fusion implants cleared in 4Q15, and can also be used with the company's PerX360 System™.

Opticage can be implanted via posterior, transforaminal or lateral approach.
Source: Interventional Spine, Inc.

Product Labels: Spinal Fusion

Tags: 510(k) Clearance, Regulatory